Other iatrogenic immunodeficiency lymphoproliferative disorder induced by corticosteroid used for an autoimmune disorder

Other iatrogenic immunodeficiency lymphoproliferative disorders (oii-LPD) are defined as lymphoid proliferations or lymphomas that occur in patients taking immunosuppressive agents (ISA) for autoimmune disorders (AID). Although methotrexate and tumor necrosis factor-alpha inhibitors cause oii-LPD, t...

Full description

Bibliographic Details
Main Authors: Kenichi Ito, Yoshihito Uchino, Kazuhiko Hirano, Naohiro Sekiguchi
Format: Article
Language:English
Published: SAGE Publishing 2022-12-01
Series:Journal of International Medical Research
Online Access:https://doi.org/10.1177/03000605221144149
_version_ 1797980650593058816
author Kenichi Ito
Yoshihito Uchino
Kazuhiko Hirano
Naohiro Sekiguchi
author_facet Kenichi Ito
Yoshihito Uchino
Kazuhiko Hirano
Naohiro Sekiguchi
author_sort Kenichi Ito
collection DOAJ
description Other iatrogenic immunodeficiency lymphoproliferative disorders (oii-LPD) are defined as lymphoid proliferations or lymphomas that occur in patients taking immunosuppressive agents (ISA) for autoimmune disorders (AID). Although methotrexate and tumor necrosis factor-alpha inhibitors cause oii-LPD, the association between corticosteroids and lymphomagenesis remains unknown. Herein, we present the case of a 51-year-old woman with oii-LPD caused by corticosteroid use for autoimmune hemolytic anemia (AIHA). The diagnosis of AIHA was made in May 2016, and AIHA had been well-controlled for 5 years with oral prednisolone (PSL). During a regular follow-up visit in March 2022, an abnormal increase in atypical lymphoid cells in the peripheral blood was found. The bone marrow biopsy specimens showed local aggregations of large cells that were identified as lymphoplasmacytic cells and plasma cells, and that were positive for cluster of differentiation (CD)19 and CD20, with apparent nucleoli among the diffuse infiltration of atypical small lymphocytes. The large cells were partially positive for the Epstein–Barr encoding region in situ hybridization and latent membrane protein 1, which confirmed Epstein–Barr virus (EBV)-affected lymphomagenesis. To our knowledge, this is the first report of an oii-LPD case shown to be induced by corticosteroid use for AID.
first_indexed 2024-04-11T05:58:14Z
format Article
id doaj.art-0bb30f081e3247c2875b8ac263cf3d27
institution Directory Open Access Journal
issn 1473-2300
language English
last_indexed 2024-04-11T05:58:14Z
publishDate 2022-12-01
publisher SAGE Publishing
record_format Article
series Journal of International Medical Research
spelling doaj.art-0bb30f081e3247c2875b8ac263cf3d272022-12-22T04:41:49ZengSAGE PublishingJournal of International Medical Research1473-23002022-12-015010.1177/03000605221144149Other iatrogenic immunodeficiency lymphoproliferative disorder induced by corticosteroid used for an autoimmune disorderKenichi ItoYoshihito UchinoKazuhiko HiranoNaohiro SekiguchiOther iatrogenic immunodeficiency lymphoproliferative disorders (oii-LPD) are defined as lymphoid proliferations or lymphomas that occur in patients taking immunosuppressive agents (ISA) for autoimmune disorders (AID). Although methotrexate and tumor necrosis factor-alpha inhibitors cause oii-LPD, the association between corticosteroids and lymphomagenesis remains unknown. Herein, we present the case of a 51-year-old woman with oii-LPD caused by corticosteroid use for autoimmune hemolytic anemia (AIHA). The diagnosis of AIHA was made in May 2016, and AIHA had been well-controlled for 5 years with oral prednisolone (PSL). During a regular follow-up visit in March 2022, an abnormal increase in atypical lymphoid cells in the peripheral blood was found. The bone marrow biopsy specimens showed local aggregations of large cells that were identified as lymphoplasmacytic cells and plasma cells, and that were positive for cluster of differentiation (CD)19 and CD20, with apparent nucleoli among the diffuse infiltration of atypical small lymphocytes. The large cells were partially positive for the Epstein–Barr encoding region in situ hybridization and latent membrane protein 1, which confirmed Epstein–Barr virus (EBV)-affected lymphomagenesis. To our knowledge, this is the first report of an oii-LPD case shown to be induced by corticosteroid use for AID.https://doi.org/10.1177/03000605221144149
spellingShingle Kenichi Ito
Yoshihito Uchino
Kazuhiko Hirano
Naohiro Sekiguchi
Other iatrogenic immunodeficiency lymphoproliferative disorder induced by corticosteroid used for an autoimmune disorder
Journal of International Medical Research
title Other iatrogenic immunodeficiency lymphoproliferative disorder induced by corticosteroid used for an autoimmune disorder
title_full Other iatrogenic immunodeficiency lymphoproliferative disorder induced by corticosteroid used for an autoimmune disorder
title_fullStr Other iatrogenic immunodeficiency lymphoproliferative disorder induced by corticosteroid used for an autoimmune disorder
title_full_unstemmed Other iatrogenic immunodeficiency lymphoproliferative disorder induced by corticosteroid used for an autoimmune disorder
title_short Other iatrogenic immunodeficiency lymphoproliferative disorder induced by corticosteroid used for an autoimmune disorder
title_sort other iatrogenic immunodeficiency lymphoproliferative disorder induced by corticosteroid used for an autoimmune disorder
url https://doi.org/10.1177/03000605221144149
work_keys_str_mv AT kenichiito otheriatrogenicimmunodeficiencylymphoproliferativedisorderinducedbycorticosteroidusedforanautoimmunedisorder
AT yoshihitouchino otheriatrogenicimmunodeficiencylymphoproliferativedisorderinducedbycorticosteroidusedforanautoimmunedisorder
AT kazuhikohirano otheriatrogenicimmunodeficiencylymphoproliferativedisorderinducedbycorticosteroidusedforanautoimmunedisorder
AT naohirosekiguchi otheriatrogenicimmunodeficiencylymphoproliferativedisorderinducedbycorticosteroidusedforanautoimmunedisorder